$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

$hcsg Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000073101217000102 Filed on October 27, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$499.4M	$491.4M	$392.7M
YoY Change	25.3%	25.11%	9.04%
Cost Of Revenue	$430.8M	$426.9M	$336.3M
YoY Change	26.37%	26.93%	8.97%
Gross Profit	$63.70M	$64.43M	$56.39M
YoY Change	10.4%	14.25%	9.46%
Gross Profit Margin	12.76%	13.11%	14.36%
Selling, General & Admin	$33.60M	$32.94M	$27.18M
YoY Change	23.53%	21.18%	15.94%
% of Gross Profit	52.75%	51.12%	48.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.600M	$1.100M	$1.100M
YoY Change	36.84%	0.0%	6.18%
% of Gross Profit	4.08%	1.71%	1.95%
Operating Expenses	$33.60M	$32.94M	$27.18M
YoY Change	23.53%	21.18%	15.94%
Operating Profit	$30.10M	$31.49M	$29.21M
YoY Change	-1.31%	7.8%	4.05%
Interest Expense	$4.600M	$1.400M	$1.400M
YoY Change	4500.0%	0.0%	-207.69%
% of Operating Profit	15.28%	4.45%	4.79%
Other Income/Expense, Net
YoY Change
Pretax Income	$34.68M	$32.93M	$30.57M
YoY Change	13.59%	7.72%	14.32%
Income Tax	$14.50M	$9.458M	$10.86M
% Of Pretax Income	41.81%	28.72%	35.52%
Net Earnings	$20.19M	$23.47M	$19.71M
YoY Change	-0.56%	19.08%	15.36%
Net Earnings / Revenue	4.04%	4.78%	5.02%
Basic Earnings Per Share	$0.27	$0.32	$0.27
Diluted Earnings Per Share	$0.27	$0.31	$0.27
COMMON SHARES
Basic Shares Outstanding	73.27M shares	73.46M shares	72.84M shares
Diluted Shares Outstanding		74.54M shares	73.59M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.80M	$81.40M	$105.0M
YoY Change	-9.61%	-22.48%	1.35%
Cash & Equivalents	$9.557M	$11.01M	$24.33M
Short-Term Investments	$73.20M	$70.40M	$80.60M
Other Short-Term Assets	$23.50M	$25.60M	$16.40M
YoY Change	67.86%	56.1%	27.13%
Inventory	$42.40M	$41.50M	$37.60M
Prepaid Expenses	$23.52M	$25.63M	$16.38M
Receivables	$378.7M	$367.0M	$265.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$527.4M	$515.5M	$424.5M
YoY Change	27.2%	21.46%	17.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.51M	$13.50M	$13.28M
YoY Change	0.4%	1.69%	0.18%
Goodwill	$51.08M	$51.08M	$44.44M
YoY Change	14.96%	14.96%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.264M	$1.264M	$48.00K
YoY Change	2533.33%	2533.33%	14.29%
Total Long-Term Assets	$148.6M	$146.0M	$112.4M
YoY Change	30.55%	29.95%	-0.41%
TOTAL ASSETS
Total Short-Term Assets	$527.4M	$515.5M	$424.5M
Total Long-Term Assets	$148.6M	$146.0M	$112.4M
Total Assets	$676.0M	$661.5M	$536.8M
YoY Change	27.92%	23.23%	13.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$74.46M	$62.32M	$39.53M
YoY Change	73.52%	57.66%	4.07%
Accrued Expenses	$58.90M	$77.30M	$66.80M
YoY Change	17.1%	15.72%	23.7%
Deferred Revenue
YoY Change
Short-Term Debt	$35.40M	$25.00M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$184.2M	$175.4M	$115.7M
YoY Change	82.58%	51.62%	24.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$91.90M	$95.70M	$90.10M
YoY Change	3.61%	6.22%	6.25%
Total Long-Term Liabilities	$91.90M	$95.70M	$90.10M
YoY Change	3.61%	6.22%	6.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$184.2M	$175.4M	$115.7M
Total Long-Term Liabilities	$91.90M	$95.70M	$90.10M
Total Liabilities	$276.1M	$271.1M	$205.7M
YoY Change	45.62%	31.79%	15.76%
SHAREHOLDERS EQUITY
Retained Earnings	$163.9M	$157.7M	$124.1M
YoY Change	25.14%	27.02%	12.05%
Common Stock	$245.1M	$241.8M	$216.3M
YoY Change	12.23%	11.78%	9.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$9.858M	$9.822M	$10.61M
YoY Change	-3.21%	-7.44%	-3.07%
Treasury Stock Shares	1.524M shares	1.525M shares	1.677M shares
Shareholders Equity	$400.0M	$390.5M	$331.1M
YoY Change
Total Liabilities & Shareholders Equity	$676.0M	$661.5M	$536.8M
YoY Change	27.92%	23.23%	13.06%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$20.19M	$23.47M	$19.71M
YoY Change	-0.56%	19.08%	15.36%
Depreciation, Depletion And Amortization	$2.600M	$1.100M	$1.100M
YoY Change	36.84%	0.0%	6.18%
Cash From Operating Activities	$4.500M	$9.700M	$17.70M
YoY Change	28.57%	-45.2%	-6.84%
INVESTING ACTIVITIES
Capital Expenditures	-$1.400M	-$1.300M	-$900.0K
YoY Change	-6.67%	44.44%	-47.06%
Acquisitions
YoY Change
Other Investing Activities	-$3.500M	-$2.400M	-$2.200M
YoY Change	-137.23%	9.09%	-95.33%
Cash From Investing Activities	-$4.900M	-$3.800M	-$3.100M
YoY Change	-162.82%	22.58%	-93.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.100M	-2.000M	-11.90M
YoY Change	-90.76%	-83.19%	0.85%
NET CHANGE
Cash From Operating Activities	4.500M	9.700M	17.70M
Cash From Investing Activities	-4.900M	-3.800M	-3.100M
Cash From Financing Activities	-1.100M	-2.000M	-11.90M
Net Change In Cash	-1.500M	3.900M	2.700M
YoY Change	150.0%	44.44%	-106.49%
FREE CASH FLOW
Cash From Operating Activities	$4.500M	$9.700M	$17.70M
Capital Expenditures	-$1.400M	-$1.300M	-$900.0K
Free Cash Flow	$5.900M	$11.00M	$18.60M
YoY Change	18.0%	-40.86%	-10.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	hcsg	Stock Contingently Issuable Value Acquisitions StockContingentlyIssuableValueAcquisitions	4438000	USD
	hcsg	Unrealized Gain Loss On Securities Related To Deferred Compensation Fund UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund	1041000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000731012
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73273000	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE SERVICES GROUP INC
CY2016Q4	hcsg	Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities	1	financial_institution
CY2017Q3	hcsg	Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities	1	financial_institution
	hcsg	Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans	2748000	USD
	hcsg	Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans	0	USD
	hcsg	Increase Decrease In Deferred Compensation Funding IncreaseDecreaseInDeferredCompensationFunding	941000	USD
	hcsg	Increase Decrease In Deferred Compensation Funding IncreaseDecreaseInDeferredCompensationFunding	-83000	USD
	hcsg	Line Of Credit Facility Number Of Financial Covenants LineOfCreditFacilityNumberOfFinancialCovenants	1	financial_covenant
	hcsg	Lineof Credit Facility Increase Decrease Remaining Borrowing Capacity LineofCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity	-74200000	USD
	hcsg	Period Of Amortization Of Inventories And Supplies PeriodOfAmortizationOfInventoriesAndSupplies	P24M
	hcsg	Related Party Transaction Fees Paid Related Party As Percentage Of Overall Related Party Revenues RelatedPartyTransactionFeesPaidRelatedPartyAsPercentageOfOverallRelatedPartyRevenues	0.05
	hcsg	Related Party Transaction Fees Paid Related Party As Percentage Of Overall Related Party Revenues RelatedPartyTransactionFeesPaidRelatedPartyAsPercentageOfOverallRelatedPartyRevenues	0.05
	hcsg	Service Agreements Duration Of Service ServiceAgreementsDurationOfService	P1Y
	hcsg	Share Based Compensation Arrangement By Share Based Payment Award Maximum Term Of Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumTermOfGrants	P10Y
CY2016Q3	hcsg	Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	34.14
	hcsg	Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	34.14
CY2017Q3	hcsg	Share Based Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	39.38
	hcsg	Unrealized Gain Loss On Securities Related To Deferred Compensation Fund UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund	3351000	USD
CY2016Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	271276000	USD
CY2017Q3	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	367009000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42912000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	62323000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7686000	USD
CY2017Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10781000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20564000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21927000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-319000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	226000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-2000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1750000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.251
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	844000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1363000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	217664000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	241008000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3773000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3113000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	21651000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	-632000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4138000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	19346000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	28671000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	515542000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6911000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9795000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	178000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1379000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.019
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	668000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	80000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	68220000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2016Q4	us-gaap	Assets Assets	528446000	USD
CY2017Q3	us-gaap	Assets Assets	661542000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	414624000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	69085000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	973000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	23879000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	16435000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1403000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	67730000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	70384000	USD
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	171000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-17000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	25756000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33189000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24327000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23853000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11005000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8862000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12848000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3400000	shares
CY2017Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.18625
CY2017Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.18750
CY2017Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.18875
CY2016Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18500
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.55125
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.19000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.56625
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74204000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74791000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72601000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73266000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	742000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	748000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19342000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	57862000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23554000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	69203000	USD
CY2016Q3	us-gaap	Cost Of Services CostOfServices	336340000	USD
	us-gaap	Cost Of Services CostOfServices	998595000	USD
CY2017Q3	us-gaap	Cost Of Services CostOfServices	426924000	USD
	us-gaap	Cost Of Services CostOfServices	1179816000	USD
CY2016Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	24653000	USD
CY2017Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	27886000	USD
CY2016Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	24119000	USD
CY2017Q3	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	27387000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9822000	USD
CY2017Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9196000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	1100000	USD
	us-gaap	Depreciation Depreciation	3500000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	1100000	USD
	us-gaap	Depreciation Depreciation	3700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5632000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6342000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	41302000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22303000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48786000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12700000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14672000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11659000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9858000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4363000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1116000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4165000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4165000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4165000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4165000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14409000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32075000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	44438000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	51084000	USD
CY2016	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	30571000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	89858000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	32930000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	98287000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10860000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32761000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9458000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30247000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	54954000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	103697000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7870000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7865000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	2284000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	3733000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1295000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	997000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-6774000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1102000	USD
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	22065000	USD
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	28575000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5279000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11658000	USD
	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	4870000	USD
	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	4992000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1053000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	929000	USD
CY2016Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1359000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2548000	USD
CY2017Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1439000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4523000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	528446000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	661542000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	100871000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	175382000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2017Q3	us-gaap	Line Of Credit LineOfCredit	25000000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	200800000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	67730000	USD
CY2017Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	70384000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32415000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5893000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14345000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10077000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37898000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3122000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	19711000	USD
	us-gaap	Net Income Loss NetIncomeLoss	57097000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	23472000	USD
	us-gaap	Net Income Loss NetIncomeLoss	68040000	USD
CY2016Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	7531000	USD
CY2017Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11495000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	909000	USD
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	1162000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4397000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3665000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1264000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	400000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	600000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	765000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1163000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-369000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	765000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	82000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1163000	USD
CY2016Q4	us-gaap	Other Inventory OtherInventory	37800000	USD
CY2017Q3	us-gaap	Other Inventory OtherInventory	41516000	USD
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13624000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	39849000	USD
CY2017Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13750000	USD
CY2017Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13883000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	41302000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	41300000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4584000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18751000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	22149000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3908000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3962000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13965000	USD
CY2017Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	25628000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	84000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	71000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	8137000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20354000	USD
CY2016Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3000000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	8100000	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5700000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	20200000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	177000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	264000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	25000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5600000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10338000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34019000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35426000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13455000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13499000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3200000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000000	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	144000	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-1000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	120000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	120000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	130940000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	157678000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	392734000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1164097000	USD
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	491355000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1366721000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27182000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	78192000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32940000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93141000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.020
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.260
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.38
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	800000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1123000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4600000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	93000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	33.66
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	544000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.52
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65589000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2615000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2553000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.61
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.27
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.39
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	36950000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y6M
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	513000	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2501000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	71000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	501000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2091000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	10338000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	338842000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	390456000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1603000	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1525000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10185000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	9822000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	753000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	717000	shares
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1077000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	980000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73592000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73435000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74538000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74252000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72839000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72718000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73461000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73272000	shares
CY2016Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	23573000	USD
CY2017Q3	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	24827000	USD
CY2016Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	64080000	USD
CY2017Q3	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	67818000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial instruments that are subject to concentrations of credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, substantially all of the Company’s cash and cash equivalents and marketable securities were held in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> large financial institution located in the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s clients are concentrated in the health care industry and are primarily providers of long-term care. The revenues of many of the Company’s clients are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could be made which could directly impact the governmental reimbursement programs in which the clients participate. The full effect of any such programs would not be realized until these laws are fully implemented and governmental agencies issue applicable regulations or guidance. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.</font></div></div>

Files In Submission

Name	View Source	Status
0000731012-17-000102-index-headers.html	Edgar Link	pending
0000731012-17-000102-index.html	Edgar Link	pending
0000731012-17-000102.txt	Edgar Link	pending
0000731012-17-000102-xbrl.zip	Edgar Link	pending
ceosection302certification.htm	Edgar Link	pending
cfosection302certification.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hcsg-20170930.xml	Edgar Link	completed
hcsg-20170930.xsd	Edgar Link	pending
hcsg-20170930_cal.xml	Edgar Link	unprocessable
hcsg-20170930_def.xml	Edgar Link	unprocessable
hcsg-20170930_lab.xml	Edgar Link	unprocessable
hcsg-20170930_pre.xml	Edgar Link	unprocessable
hcsg10qq32017.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
section906certificationq32.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

2017 Q4 Form 10-Q Financial Statement

#000073101217000102 Filed on October 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG HEALTHCARE SERVICES GROUP INC Stock $hcsg

2017 Q4 Form 10-Q Financial Statement

#000073101217000102 Filed on October 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg